Stockscreener 앱 받기
5.66
0.35%
-0.02
전일 마감가:
$5.68
열려 있는:
$5.69
하루 거래량:
3,433
Relative Volume:
0.08
시가총액:
$338.49M
수익:
$117.93M
순이익/손실:
$5.00M
주가수익비율:
43.07
EPS:
0.1314
순현금흐름:
$-12.91M
1주 성능:
+564.71%
1개월 성능:
+515.55%
6개월 성능:
+581.93%
1년 성능:
+249.86%
1일 변동 폭
$5.69
$5.89
1주일 범위
$4.80
$6.10
52주 변동 폭
$0.68
$6.10
Intercure Ltd Stock (INCR) Company Profile
Compare INCR vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
5.715 | 51.47M | 117.93M | 5.00M | -12.91M | 0.1314 |
TAK
Takeda Pharmaceutical Co Adr
|
18.02 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.07 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.56 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.67 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
516.89 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-05-18 | 업그레이드 | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd 주식(INCR)의 최신 뉴스
Intercure (INCR) Chart: Adds 0.23% to Close at $0.87 in the Current Update; Technical Setup: Traders Can Monitor the $0.83-$0.91 Range in Latest TradingMax Pain Level - dars.gov.et
InterCure announces 1-for-5 reverse stock split starting Monday By Investing.com - Investing.com Australia
Intercure (NASDAQ: INCR) issues stock for ISHI deal's first closing - Stock Titan
BRIEF-Intercure Ltd. Announces 1-For-5 Reverse Share Split - Bitget
InterCure announces 1-for-5 reverse stock split starting Monday - Investing.com
InterCure Ltd. Announces 1-for-5 Reverse Share Split - The Manila Times
Intercure Ltd. (INCR) Slips to $0.96: Support Test Looms as Cannabis Stock Faces PressureRVOL Spike - dars.gov.et
InterCure Ltd (INCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alon Shmuel Granot Net Worth (2026) - GuruFocus
InterCure Shareholders Approve Proposal at August 11 Extraordinary Meeting - TipRanks
InterCure holds extraordinary shareholder meeting - Bitget
InterCure Ltd. (INCR) shareholders back proposal at August 11, 2026 special meeting - Stock Titan
Intercure (INCR) Advances 5.91% to $0.98, Approaching Key Resistance at $1.03Factor Crowding - vinanet.vn
InterCure Ltd (INCR) Stock News Today - TradingKey
InterCure Ltd (INCR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Intercure Ltd. Ordinary Shares Share Price Live Today – NASDAQ:INCR Stock Price, Chart, News, History - Upstox
Intercure (INCR) Slips 1.16% to $0.95, Hovering Above Key SupportRVOL Spike - dars.gov.et
Intercure Details Voting Procedures for August 11 Extraordinary Shareholder Meeting - TipRanks
InterCure (INCR) sets voting process for August 11 extraordinary shareholder meeting - Stock Titan
INCR Q2 2023 Earnings: EPS Surprises to the Upside Despite Stock DeclineAdjusted Earnings Analysis - vinanet.vn
InterCure Ltd. Revenue Breakdown – TASE:INCR - TradingView
InterCure Ltd (INCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
InterCure Ltd (INCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
InterCure Ltd (INCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
InterCure Ltd (INCR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
InterCure Ltd (INCR) Income Statement - TradingKey
INCR|InterCure Ltd|Price:0.939|Chg%:-0.020 - TradingKey
INCR|InterCure Ltd|Price:0.927|Chg%:+0.025 - TradingKey
InterCure Ltd (INCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
INCR Q2 2023 Earnings: EPS Surprises to the Upside as Profitability Exceeds ExpectationsHealthcare Earnings Report - vinanet.vn
What Is Driving InterCure (NASDAQ:INCR) on the Nasdaq? - Kalkine Media
Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% as Stock GainsRevenue Growth Outlook - dars.gov.et
InterCure (INCR) seeks approval for 5-for-1 reverse share split - Stock Titan
Alexander Rabinovich Net Worth (2026) - GuruFocus
Lennie Grinbaum Michelson Net Worth (2026) - GuruFocus
INCR Q2 2023 Earnings: EPS Surprise Beats Estimates Amid Undisclosed RevenueAnnual Earnings Summary - vinanet.vn
Price to book forward of Intercure Ltd. – NASDAQ:INCR - TradingView
ETFs Investing in InterCure Ltd. Stocks - TradingView
Intercure Ltd. (INCR) Slides 3% as Support at $0.90 Comes Into FocusFibonacci Entry Signals - dars.gov.et
Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Surges Past Estimates with 28.68% SurpriseCost Structure Review - dars.gov.et
InterCure Ltd. Actuals & Estimates (TASE:INCR) - TradingView
Price to earnings forward of InterCure Ltd. – TASE:INCR - TradingView
InterCure Ltd. Actuals & Estimates (BOATS:INCR) - TradingView
Intercure (INCR) Sees Modest Decline, Tests Key Support Near $1.00Dark Pool Sentiment - po-news-eg.net
Price to sales forward of InterCure Ltd. – TASE:INCR - TradingView
Enterprise value to EBITDA forward of InterCure Ltd. – TASE:INCR - TradingView
Intercure Ltd. (INCR) Q2 2023 Earnings: EPS Beats Estimates by 28.7% Amid Uncertain Revenue PictureEnergy Earnings Report - dars.gov.et
InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds - Sahm
InterCure Secures NIS 22 Million Private Placement to Fund Global Medical Cannabis Expansion - The Globe and Mail
InterCure secures $7.4M funding commitment, may rise to $18.6M - Investing.com UK
InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. - marketscreener.com
Intercure Ltd (INCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.87%
자본화:
|
볼륨(24시간):